Nurtec Odt Tablet, Orally Disintegrating
NDC Package 72618-3000-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Nurtec Odt (rimegepant sulfate) tablets is nURTEC ODT is indicated for the acute treatment of migraine with or without aura in adults.Limitations of UseNURTEC ODT is not indicated for the preventive treatment of migraine. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 72618-3000 and is authorized under FDA application NDA212728.

Identification & Billing

NDC Package Code
72618-3000-2
Package Description
1 BLISTER PACK in 1 CARTON / 8 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Product Code
72618-3000
11-Digit Billing Format
72618300002
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nurtec Odt
Non-Proprietary Name
Rimegepant Sulfate
Substance Name
Rimegepant Sulfate
Dosage Form
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
RIMEGEPANT SULFATE 75 mg/1
Pharmacologic Class
Usage Information
NURTEC ODT is indicated for the acute treatment of migraine with or without aura in adults.Limitations of UseNURTEC ODT is not indicated for the preventive treatment of migraine.

Regulatory & Marketing

Labeler Name
Pfizer Laboratories Div Pfizer Inc
Product Type
Human Prescription Drug
FDA Application #
NDA212728
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-05-2020
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72618-3000-2 identifies a specific commercial package of 1 blister pack in 1 carton / 8 tablet, orally disintegrating in 1 blister pack of Nurtec Odt, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. This tablet, orally disintegrating is formulated for oral use and contains rimegepant sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on March 05, 2020. The current certification is valid through December 31, 2027.

How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72618300002. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
72618-3000-2
11-Digit CMS (5-4-2)
72618-3000-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.